Nostrum Laboratories, Inc. recalls
2 notices naming Nostrum Laboratories, Inc. as the recalling firm, since July 11, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Nostrum Laboratories, Inc.: Sucralfate Tablets
Hazard (FDA): CGMP Deviations: The recalling firm filed for Chapter 11 in September 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity…
FDAMedicines
Nostrum Laboratories, Inc. Issues Voluntary Nationwide Recall of Sucralfate Tablets USP 1 Gram Within Expiry
Hazard (FDA): Company closure and discontinuation of quality activities.
FDAMedicines